SCLX

VICKERS VANTAGE CORP I

SCLX·G9440B107·UW·Common Stock·Healthcare - Drug Manufacturers - General

SCLX (VICKERS VANTAGE CORP I) is held by 0 institutional investors as of Q4 2022. Net institutional sentiment: Bearish.

0
Holders
$0
Total Value
0% (11)
Consensus
0 buying - 11 selling
13F: Insider & Congress: Updated regularly
SCLX

Smart Money Verdict

View all
Loading verdict
Held by 0 funds

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Jul 7, 2026 · Activists none · Congress none

InsiderSLSCLX Stock Acquisition JV LLCOther 500K shJul 3, 2026
InsiderSCScilex Holding CoSell $5.2MDec 30, 2025
InsiderSCScilex Holding CoSell $4.8MDec 29, 2025
Checking access…

Top Holders

Checking access…
Action
Exited
0(-100.0%)$1.5M0.0%-61.37%
0
Exited
0(-100.0%)$4M0.0%—
0
Exited
0(-100.0%)$122,0000.0%-59.84%
0
Exited
0(-100.0%)$3.1M0.0%-59.57%
0
Exited
0(-100.0%)$5.2M0.0%-59.57%
0
Exited
0(-100.0%)$352,0000.0%-61.37%
0
Exited
0(-100.0%)$134,3110.0%-61.37%
0
Exited
0(-100.0%)$263,0000.0%-61.04%
0
Exited
0(-100.0%)$4.4M0.0%-60.21%
0
Exited
0(-100.0%)$818,0000.0%-61.20%
0
Exited
0(-100.0%)$963,0000.0%-60.66%
0
Exited
0(-100.0%)$46,0000.0%-60.94%
0
SCLXSCLXVICKERS VANTAGE CORP I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used